Mark C Faulkner

This inventor holds 16 USPTO granted patents and 11 published patent applications, plus 1 CIPO patent and 1 EPO patent, primarily in Pharmaceutical Compositions. Top assignees: Vireo Systems, Inc., The Board of Regents of the University of Nebraska. Active years: 2009-2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Mark C Faulkner. Retrieved from https://idiyas.com/inventor/mark-c-faulkner

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

USPTO Granted Patents = 16 (Patent Applications = 11)

% Patents Active = 68.8

CIPO Patents = 1 (Patent Applications = 3)

EPO Patents = 1 (Patent Applications = 8)

Average Co-Inventor Count = 2.7

ph-index = 5

Forward Citations = 76(Granted Patents)

Company Filing History:

The Board of Regents of the University of Nebraska

patents

where one patent can have more than one assignee

Years Active: 2009-2026

Loading Chart...

Areas of Expertise:

Osteoarthritis Treatment

Antiviral Compounds

Neuroprotection

Vaginal Infections

Parenteral Delivery

Creatine Supplementation

Influenza Treatment

Therapeutic Compositions

Neurodegeneration

Drug Formulations

Oral Delivery

Medical Devices

16 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12629348 - Method and composition for treating osteoarthritis (2026-05-19),

2. 12564567 - Antiviral therapeutic compounds and compositions for use in treatment of coronavirus and influenza virus (2026-03-03),

3. 12109195 - Compositions and methods for treatment of vaginal infections (2024-10-08),

4. 12011469 - Parenteral delivery device and methods of use (2024-06-18),

5. 11826334 - Antiviral therapeutic compounds and compositions for use in treatment of coronavirus and influenza virus (2023-11-28),

6. 11160776 - Compositions and methods for neuroprotection and treatment of neurodegeneration (2021-11-02),

7. 10881630 - Creatine oral supplementation using creatine hydrochloride salt (2021-01-05),

8. 10583105 - Compositions and methods for neuroprotection and treatment of neurodegeneration (2020-03-10),

9. 10342771 - Creatine oral supplementation using creatine hydrochloride salt (2019-07-09),

10. 10245245 - Compositions and methods for neuroprotection and treatment of neurodegeneration (2019-04-02),

11. 9962352 - Creatine oral supplementation using creatine hydrochloride salt (2018-05-08),

12. 9486424 - Creatine oral supplementation using creatine hydrochloride salt (2016-11-08),

13. 8962685 - Creatine oral supplementation using creatine hydrochloride salt (2015-02-24),

14. 8354450 - Creatine oral supplementation using creatine hydrochloride salt (2013-01-15),

15. 8026385 - Creatine oral supplementation using creatine hydrochloride salt (2011-09-27),

Title: The Innovative Mind of Mark C Faulkner

Introduction

Mark C Faulkner, an inventive spirit hailing from Madison, TN, has made significant contributions to the field of medical treatments through his extensive work as an inventor. With a remarkable portfolio of 14 patents, his focus primarily lies in the development of compositions aimed at treating vaginal infections and enhancing delivery methods for medical treatments.

Latest Patents

Faulkner's latest innovations include:

1. **Compositions and methods for treatment of vaginal infections**: This patent outlines compositions that include creatinine, such as protonated creatinine or creatinine salts, intended for treating and preventing vaginal infections, like bacterial vaginosis. The method aims to reduce the incidence and risk of sexually transmitted infections (STIs) and provides a therapeutic approach to possibly prevent the recurrence of such infections.

2. **Parenteral delivery device and methods of use**: This invention involves a parenteral delivery device designed to administer a multi-system treatment to a specified location in the body. The device comprises an inner compartment encapsulating one treatment system and an outer compartment encapsulating another, allowing for different mechanisms of action tailored for the treatment of vaginal infections.

Career Highlights

Throughout his career, Mark Faulkner has collaborated with notable organizations, including Vireo Systems, Inc. and the University of Nebraska. His work has been instrumental in bridging the gap between research and practical applications in medicine.

Collaborations

Faulkner's journey has been enriched by collaborations with esteemed colleagues, such as Donald W. Miller and Jonathan L. Vennerstrom. These partnerships have fostered innovative research and development in the medical field, showcasing the power of teamwork in achieving groundbreaking advancements.

Conclusion

Mark C Faulkner's inventive contributions to medical science exemplify the spirit of innovation. With a strong foundation of patents and collaborations, he continues to impact the treatment landscape positively. His work not only addresses pressing medical needs but also highlights the importance of creativity and collaboration in advancing healthcare solutions.

Profile summary based on public USPTO records.